NET-related gene signature for predicting AML prognosis

Abstract Acute Myeloid Leukemia (AML) is a malignant blood cancer with a high mortality rate. Neutrophil extracellular traps (NETs) influence various tumor outcomes. However, NET-related genes (NRGs) in AML had not yet received much attention. This study focuses on the role of NRGs in AML and their...

Full description

Bibliographic Details
Main Authors: Jiajia Wang, Huiping Wang, Yangyang Ding, Xunyi Jiao, Jinli Zhu, Zhimin Zhai
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-59464-y
_version_ 1797199406691254272
author Jiajia Wang
Huiping Wang
Yangyang Ding
Xunyi Jiao
Jinli Zhu
Zhimin Zhai
author_facet Jiajia Wang
Huiping Wang
Yangyang Ding
Xunyi Jiao
Jinli Zhu
Zhimin Zhai
author_sort Jiajia Wang
collection DOAJ
description Abstract Acute Myeloid Leukemia (AML) is a malignant blood cancer with a high mortality rate. Neutrophil extracellular traps (NETs) influence various tumor outcomes. However, NET-related genes (NRGs) in AML had not yet received much attention. This study focuses on the role of NRGs in AML and their interaction with the immunological microenvironment. The gene expression and clinical data of patients with AML were downloaded from the TCGA-LAML and GEO cohorts. We identified 148 NRGs through the published article. Univariate Cox regression was used to analyze the association of NRGs with overall survival (OS). The least absolute shrinkage and selection operator were utilized to assess the predictive efficacy of NRGs. Kaplan–Meier plots visualized survival estimates. ROC curves assessed the prognostic value of NRG-based features. A nomogram, integrating clinical information and prognostic scores of patients, was constructed using multivariate logistic regression and Cox proportional hazards regression models. Twenty-seven NRGs were found to significantly impact patient OS. Six NRGs—CFTR, ENO1, PARVB, DDIT4, MPO, LDLR—were notable for their strong predictive ability regarding patient survival. The ROC values for 1-, 3-, and 5-year survival rates were 0.794, 0.781, and 0.911, respectively. In the training set (TCGA-LAML), patients in the high NRG risk group showed a poorer prognosis (p < 0.001), which was validated in two external datasets (GSE71014 and GSE106291). The 6-NRG signature and corresponding nomograms exhibit superior predictive accuracy, offering insights for pre-immune response evaluation and guiding future immuno-oncology treatments and drug selection for AML patients.
first_indexed 2024-04-24T07:15:15Z
format Article
id doaj.art-76d5e7932f1c47db8ea87159079e4a91
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-24T07:15:15Z
publishDate 2024-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-76d5e7932f1c47db8ea87159079e4a912024-04-21T11:19:39ZengNature PortfolioScientific Reports2045-23222024-04-0114111210.1038/s41598-024-59464-yNET-related gene signature for predicting AML prognosisJiajia Wang0Huiping Wang1Yangyang Ding2Xunyi Jiao3Jinli Zhu4Zhimin Zhai5Department of Hematology, The Second Affiliated Hospital of Anhui Medical UniversityDepartment of Hematology, The Second Affiliated Hospital of Anhui Medical UniversityDepartment of Hematology, The Second Affiliated Hospital of Anhui Medical UniversityDepartment of Hematology, The Second Affiliated Hospital of Anhui Medical UniversityDepartment of Hematology, The Second Affiliated Hospital of Anhui Medical UniversityDepartment of Hematology, The Second Affiliated Hospital of Anhui Medical UniversityAbstract Acute Myeloid Leukemia (AML) is a malignant blood cancer with a high mortality rate. Neutrophil extracellular traps (NETs) influence various tumor outcomes. However, NET-related genes (NRGs) in AML had not yet received much attention. This study focuses on the role of NRGs in AML and their interaction with the immunological microenvironment. The gene expression and clinical data of patients with AML were downloaded from the TCGA-LAML and GEO cohorts. We identified 148 NRGs through the published article. Univariate Cox regression was used to analyze the association of NRGs with overall survival (OS). The least absolute shrinkage and selection operator were utilized to assess the predictive efficacy of NRGs. Kaplan–Meier plots visualized survival estimates. ROC curves assessed the prognostic value of NRG-based features. A nomogram, integrating clinical information and prognostic scores of patients, was constructed using multivariate logistic regression and Cox proportional hazards regression models. Twenty-seven NRGs were found to significantly impact patient OS. Six NRGs—CFTR, ENO1, PARVB, DDIT4, MPO, LDLR—were notable for their strong predictive ability regarding patient survival. The ROC values for 1-, 3-, and 5-year survival rates were 0.794, 0.781, and 0.911, respectively. In the training set (TCGA-LAML), patients in the high NRG risk group showed a poorer prognosis (p < 0.001), which was validated in two external datasets (GSE71014 and GSE106291). The 6-NRG signature and corresponding nomograms exhibit superior predictive accuracy, offering insights for pre-immune response evaluation and guiding future immuno-oncology treatments and drug selection for AML patients.https://doi.org/10.1038/s41598-024-59464-yNeutrophil extracellular trapsAMLPrognostic modelTumor microenvironmentImmunotherapy
spellingShingle Jiajia Wang
Huiping Wang
Yangyang Ding
Xunyi Jiao
Jinli Zhu
Zhimin Zhai
NET-related gene signature for predicting AML prognosis
Scientific Reports
Neutrophil extracellular traps
AML
Prognostic model
Tumor microenvironment
Immunotherapy
title NET-related gene signature for predicting AML prognosis
title_full NET-related gene signature for predicting AML prognosis
title_fullStr NET-related gene signature for predicting AML prognosis
title_full_unstemmed NET-related gene signature for predicting AML prognosis
title_short NET-related gene signature for predicting AML prognosis
title_sort net related gene signature for predicting aml prognosis
topic Neutrophil extracellular traps
AML
Prognostic model
Tumor microenvironment
Immunotherapy
url https://doi.org/10.1038/s41598-024-59464-y
work_keys_str_mv AT jiajiawang netrelatedgenesignatureforpredictingamlprognosis
AT huipingwang netrelatedgenesignatureforpredictingamlprognosis
AT yangyangding netrelatedgenesignatureforpredictingamlprognosis
AT xunyijiao netrelatedgenesignatureforpredictingamlprognosis
AT jinlizhu netrelatedgenesignatureforpredictingamlprognosis
AT zhiminzhai netrelatedgenesignatureforpredictingamlprognosis